159 related articles for article (PubMed ID: 3410169)
1. Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.
Lamberts R; Creutzfeldt W; Stöckmann F; Jacubaschke U; Maas S; Brunner G
Digestion; 1988; 39(2):126-35. PubMed ID: 3410169
[TBL] [Abstract][Full Text] [Related]
2. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.
Creutzfeldt W; Lamberts R; Stöckmann F; Brunner G
Scand J Gastroenterol Suppl; 1989; 166():122-8; discussion 138-9. PubMed ID: 2513642
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine.
Brunner G; Creutzfeldt W
Scand J Gastroenterol Suppl; 1989; 166():101-5; discussion 111-3. PubMed ID: 2513641
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
Brunner GH; Lamberts R; Creutzfeldt W
Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
[TBL] [Abstract][Full Text] [Related]
5. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Arnold R; Hennig U; Fuchs W
Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
[TBL] [Abstract][Full Text] [Related]
6. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.
Larsson H; Carlsson E; Mattsson H; Lundell L; Sundler F; Sundell G; Wallmark B; Watanabe T; Håkanson R
Gastroenterology; 1986 Feb; 90(2):391-9. PubMed ID: 3510144
[TBL] [Abstract][Full Text] [Related]
7. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.
Larsson H; Carlsson E; Håkanson R; Mattsson H; Nilsson G; Seensalu R; Wallmark B; Sundler F
Gastroenterology; 1988 Dec; 95(6):1477-86. PubMed ID: 3181674
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histidine decarboxylase activity and ECL cell density in normal and antrectomized rats.
Sundler F; Carlsson E; Håkanson R; Larsson H; Mattsson H
Scand J Gastroenterol Suppl; 1986; 118():39-46. PubMed ID: 3460171
[TBL] [Abstract][Full Text] [Related]
9. Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells.
Creutzfeldt W; Stöckmann F; Conlon JM; Fölsch UR; Bonatz G; Wülfrath M
Digestion; 1986; 35 Suppl 1():84-97. PubMed ID: 3792674
[TBL] [Abstract][Full Text] [Related]
10. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
Brunner G; Creutzfeldt W; Harke U; Lamberts R
Digestion; 1988; 39(2):80-90. PubMed ID: 3410170
[TBL] [Abstract][Full Text] [Related]
11. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
Nishi T; Makuuchi H; Weinstein WM
Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
[TBL] [Abstract][Full Text] [Related]
12. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.
Lamberts R; Creutzfeldt W; Strüber HG; Brunner G; Solcia E
Gastroenterology; 1993 May; 104(5):1356-70. PubMed ID: 8482449
[TBL] [Abstract][Full Text] [Related]
13. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
Creutzfeldt W; Lamberts R
Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
[TBL] [Abstract][Full Text] [Related]
14. Antrectomy does not accelerate reversal of omeprazole-induced trophic effects in the rat stomach.
Axelson J; Håkanson R; Sundler F
Scand J Gastroenterol; 1992; 27(3):243-8. PubMed ID: 1502489
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
Hage E; Hendel L; Gustafsen J; Hendel J
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
17. Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats.
Ryberg B; Mattsson H; Carlsson E
Digestion; 1988; 39(2):91-9. PubMed ID: 3410171
[TBL] [Abstract][Full Text] [Related]
18. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
[TBL] [Abstract][Full Text] [Related]
20. Effect of omeprazole on gastric acid secretion and plasma gastrin in man.
Olbe L; Cederberg C; Lind T; Olausson M
Scand J Gastroenterol Suppl; 1989; 166():27-32; discussion 41-2. PubMed ID: 2690329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
